Stimulation with CXCL12 leads to activation of various pathways in SCLC cells, and CXCR4 has also been reported to activate the JAK/STAT3 pathway (Vila-Coro et al, 1999; Ahr et al, 2005). Here, CXCL12 is linked to small cell lung carcinoma.